Sunday, November 1, 2026

"3D Printing Could Transform Manufacturing of Vehicles", Says Philipp Von Hagen, Porsche's Investment Head

Via News interviewed Porsche executive Philipp von Hagen at Web Summit 2017 in Lisbon about the automaker's use of 3D printing in vehicle manufacturing and future technology goals.

LM Salvado
LM Salvado

March 7, 2018

Porsche headquarters in Stuttgart, Germany. Photo by: Morio
LISBON, Portugal (ViaNews) - We met with Philipp von Hagen in November 2017 for an interview at the Lisbon's Web Summit to understand more about Porsche's goals. Mr. Philipp von Hagen has been a Member of the Executive Board at the holding company, Porsche SE, since 2012, where he's responsible for investment management. Mr. von Hagen is also a Director of INRIX, Inc. He holds a B.Sc. in Industrial Economics from the London School of Economics & Political Science (LSE) and an M.Phil. from the University of Oxford. Porsche SE holds the majority of the ordinary shares in the Volkswagen Group, one of the world’s leading automobile manufacturers and the largest in Europe. The Volkswagen Group manages 12 brands including Audi, Bentley, Bugatti, Ducati, Lamborghini, Porsche, Seat, Skoda, Volkswagen, MAN, and Scania. Miguel Salvado: How are you finding the Web Summit so far? Philipp von Hagen: The Web Summit is a fantastic event. It's a great technology conference to have in Europe. A lot of inspiring people, great startups, as well as established companies, coming together in a phenomenal place. [caption id="attachment_3833" align="aligncenter" width="845"]Phillip von Haggen at Lisbon's Web Summit. Photo by: Miguel Salvado. Phillip von Haggen at Lisbon's Web Summit. Photo by: Miguel Salvado.[/caption] What about Lisbon, how are you finding the city so far? Lisbon is a great host and Portugal is a great country. It's a fantastic location to host the Web Summit. Tell us about Porsche SE, what are you guys doing at the Web Summit? We're really looking for new ideas. As Porsche SE, we have a large share of the VW group and as such we're very interested in the future mobility ecosystem and the future of the industry. We're constantly looking for new enabling technologies to transform our ecosystem and we're investing in those technologies. With a bit of luck, we'll find one or another investment. What new technologies are we talking about? Enabling technologies that will make mobility more accessible. On the industrial side, 3D printing could transform the manufacturing of vehicles. What about today, what are you planning on doing for this last day of the Web Summit? I just come from a meeting with Al Gore, we talked about the sustainable mobility of the future, it was very exciting bringing people together from different backgrounds and solving some real-world problems and follow up for other meetings for the next couple of days.
LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com
"3D Printing Could Transform Manufacturing of Vehicles", Says Philipp Von Hagen, Porsche's Investment Head | Via News